CMS: Medicare Programs: International Pricing Index Model for Medicare Part B Drugs

The Centers for Medicare and Medicaid Services has issued an advance notice of proposed rulemaking seeking comment on options that they should consider for testing changes to payment for certain separately payable Part B drugs and biologicals. Among other things, CMS intends to test whether phasing down the Medicare payment amount for selected Part B drugs to more closely align with international prices and allowing private-sector vendors to negotiate prices for drugs would lead to higher quality care for beneficiaries and reduced Medicare program expenditures. Comments are due by December 31, 2018.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news